| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |